COSMAX - Public Comps and Valuation Multiples

COSMAX Overview

About COSMAX

Cosmax Inc is a Korean-based specialized cosmetics research and development and manufacturing company. COSMAX develops and provides cosmetics to more than 600 cosmetics brands around the world. The key product consists of skincare, makeup, mask sheets, oriental medicine, haircare, functional cosmetics, and scents. Its products are also sold in Europe, North America, and Central and South America. The company also has four corporations in Shanghai and Guangzhou, China, Indonesia, and the United States.

Founded

1992

HQ

Employees

280

Website

cosmax.com

Sectors

Health & Beauty

Financials

LTM Revenue $1.7B

LTM EBITDA $206M

EV

$2.0B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

COSMAX Financials

As of September 2025, COSMAX reported last 12-month revenue of $1.7B and EBITDA of $206M.

In the same period, COSMAX generated $325M in LTM gross profit and $73.0M in net income.

See COSMAX valuation multiples based on analyst estimates

COSMAX P&L

In the most recent fiscal year, COSMAX reported revenue of $1.5B and EBITDA of $176M.

COSMAX expects next 12-month revenue of XXX and NTM EBITDA of XXX

See COSMAX valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$1.7B	XXX	$1.5B	XXX	XXX	XXX
Gross Profit	$325M	XXX	$293M	XXX	XXX	XXX
Gross Margin	19%	XXX	19%	XXX	XXX	XXX
EBITDA	$206M	XXX	$176M	XXX	XXX	XXX
EBITDA Margin	12%	XXX	12%	XXX	XXX	XXX
EBIT	$151M	XXX	$123M	XXX	XXX	XXX
EBIT Margin	9%	XXX	8%	XXX	XXX	XXX
Net Profit	$73.0M	XXX	$60.0M	XXX	XXX	XXX
Net Margin	4%	XXX	4%	XXX	XXX	XXX
Net Debt	XXX	XXX	$308M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for COSMAX including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $1.7B. EBITDA for the last twelve months was $206M. In the most recent fiscal year, COSMAX achieved $1.5B in revenue and $176M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$1.7B	Analyst estimates available to subscribers	$1.5B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$325M	Analyst estimates available to subscribers	$293M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	19.3% gross margin	Analyst estimates available to subscribers	19.3% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$206M	Analyst estimates available to subscribers	$176M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	12.2% EBITDA margin	Analyst estimates available to subscribers	11.6% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$151M	Analyst estimates available to subscribers	$123M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	9.0% EBIT margin	Analyst estimates available to subscribers	8.1% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$73.0M	Analyst estimates available to subscribers	$60.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	4.3% net profit margin	Analyst estimates available to subscribers	4.0% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$308M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for COSMAX

This financial data table provides comprehensive performance metrics for COSMAX, a company based in South Korea. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

COSMAX generated $1.7B in revenue over the last twelve months.
The company achieved $206M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $325M.
Net income over the last twelve months reached $73.0M.

Fiscal Year Performance

In the most recent fiscal year, COSMAX reported $1.5B in total revenue.
Fiscal year EBITDA was $176M.
The company maintained a gross profit margin of 19.3% in the most recent fiscal year.
EBITDA margin for the fiscal year was 11.6%.
Net profit margin reached 4.0% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for COSMAX. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

COSMAX Stock Performance

COSMAX has current market cap of KRW 2.26T (or $1.6B), and EV of KRW 2.93T (or $2.0B).

Market Cap Evolution

COSMAX Stock Data

As of October 17, 2025, COSMAX's stock price is KRW 199400 (or $140).

See COSMAX trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$2.0B	$1.6B	XXX	XXX	XXX	XXX	$6.37

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

COSMAX Valuation Multiples

COSMAX's trades at 1.4x EV/Revenue multiple, and 11.6x EV/EBITDA.

See valuation multiples for COSMAX and 15K+ public comps

COSMAX Financial Valuation Multiples

As of October 17, 2025, COSMAX has market cap of $1.6B and EV of $2.0B.

Equity research analysts estimate COSMAX's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

COSMAX has a P/E ratio of 21.7x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$1.6B	XXX	$1.6B	XXX	XXX	XXX
EV (current)	$2.0B	XXX	$2.0B	XXX	XXX	XXX
EV/Revenue	1.2x	XXX	1.4x	XXX	XXX	XXX
EV/EBITDA	9.9x	XXX	11.6x	XXX	XXX	XXX
EV/EBIT	13.5x	XXX	16.7x	XXX	XXX	XXX
EV/Gross Profit	6.3x	XXX	n/a	XXX	XXX	XXX
P/E	21.7x	XXX	26.4x	XXX	XXX	XXX
EV/FCF	54.3x	XXX	-30.6x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get COSMAX Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

COSMAX Margins & Growth Rates

COSMAX's last 12 month revenue growth is 13%

COSMAX's revenue per employee in the last FY averaged $5.4M, while opex per employee averaged $0.6M for the same period.

COSMAX's rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

COSMAX's rule of X is 45% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for COSMAX and other 15K+ public comps

COSMAX Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	13%	XXX	13%	XXX	XXX	XXX
EBITDA Margin	12%	XXX	12%	XXX	XXX	XXX
EBITDA Growth	17%	XXX	32%	XXX	XXX	XXX
Rule of 40	23%	XXX	25%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	45%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$5.4M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.6M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	5%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	0%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	11%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial